Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
treprostinil (remodulin) (1 trial)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 2)
Trials (1 total)
Trial APIs (1 total)